Stay updated on Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference1%
- Check43 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check58 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has added new information regarding a pilot study on combination immunotherapy for small cell lung cancer, including updates on individual participant data sharing and a new version revision, while removing previous entries related to the same study.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.